Sanofi Consumer Healthcare India Ltd has approved a final dividend of ₹55 per equity share with a face value of ₹10 each for the financial year ending December 31, 2024. The pharma company did not mention the record date for the payment of the dividend.
| Company | Value | Change | %Change |
|---|
However, the company faced a challenging quarter as its Q4 financial results showed a significant decline in earnings. It recorded a 34.8% drop in net profit, which stood at ₹44.3 crore compared to ₹67.9 crore in the same quarter last year.
In terms of revenue, the company saw a 24% decline, with earnings falling to ₹170.7 crore from ₹224.6 crore YoY.
EBITDA also dropped by 30.6%, amounting to ₹61.1 crore in Q4, as compared to ₹89.5 crore in the previous year. As a result, the company’s EBITDA margin contracted to 36.4%, from 39.9% YoY.
These figures highlight a challenging quarter for Sanofi Consumer Healthcare, despite the company’s strong multinational presence in the vaccines and medicines markets for a variety of conditions.
The company announced its Q4 results after-market hours. Its shares ended 0.4% higher on Thursday at ₹4,759.35 on the BSE.
Also Read: Walmart-backed PhonePe gears up for potential IPO on Indian exchanges
